Unveiling quality of clinical trial in China: from concern to confirmation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Unveiling quality of clinical trial in China: from concern to confirmation

Published:2024-03-06 Issue:5 Volume:44 Page:576-579
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Huang Huiyao¹,Hou Yiru¹²,Fang Hong¹,Xu Ling³,Yu Yue¹,Zhang Huifang³,Zhang Jing⁴,Tang Yu¹,Lan Gongtao⁵,Zhang Wenbao⁶,Li Ning¹^ORCID

Affiliation:

1. Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing P. R. China

2. School of Basic Medicine and Clinical Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China

3. Department of Quality Medicine Boehringer Ingelheim (China) Investment Co Ltd Shanghai P. R. China

4. Department of Clinical Development Quality Pfizer Research and Development (China) Beijing P. R. China

5. Department of Drug Registration National Medical Products Administration Beijing P. R. China

6. Bureau of Medical Administration National Health Commission Beijing P. R. China

Funder

National Key Research and Development Program of China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12528

Reference9 articles.

1. 80% of China’s clinical trial data are fraudulent, investigation finds

2. China cracks down on fake data in drug trials

3. Pharmacovigilance in China: Evolution and future challenges

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP